LANDSCAPE AND SWOT ANALYSIS
At the earliest stage of decision making (pre-clinical or Phase I), or when a quick, inexpensive overview is needed, we offer Landscape and SWOT Analyses that summarize key considerations for pricing and reimbursement, and emerging issues that could affect use and adoption. The analysis could also include comparative assessments of competing technologies, from the payers' perspectives, to help benchmark the evidence needed to demonstrate superiority.




